Download full-text PDF

Source

Publication Analysis

Top Keywords

digitalis-induced cardiac
4
cardiac arrhythmias
4
arrhythmias experimental
4
experimental study
4
study dogs
4
digitalis-induced
1
arrhythmias
1
experimental
1
study
1
dogs
1

Similar Publications

Article Synopsis
  • - Digoxin is a cardiac medication that works by blocking the sodium potassium ATPase pump, but it has a very narrow therapeutic range, meaning the amount in the body needs to be tightly monitored.
  • - Factors like age, body weight, kidney and liver function, and other medications can affect digoxin levels in the blood, increasing the risk of toxicity, which can lead to serious heart rhythm issues.
  • - A case study of an elderly man showed that digoxin toxicity, exacerbated by chronic kidney disease and lack of dose adjustment, led to fainting and a mild brain injury, highlighting the dangers of improper management of digoxin in vulnerable populations.
View Article and Find Full Text PDF

Ivabradine: pre-clinical and clinical evidence in the setting of ventricular arrhythmias.

Hippokratia

January 2022

Second Department of Cardiology and Michaelidion Cardiac Center, Medical School University of Ioannina, Ioannina, Greece.

Background: Ivabradine, an agent lowering the heart rate, acting as a funny current () specific inhibitor, is responsible for the sinoatrial node's spontaneous depolarization. According to current guidelines, it is indicated in specific heart failure populations and as a second-line treatment option to improve angina in chronic coronary syndromes.

Review Of Literature: The role of ivabradine in the setting of ventricular arrhythmias has been studied in both experimental and clinical studies.

View Article and Find Full Text PDF

The other functions of the sodium pump.

Cell Calcium

December 2019

Department of Cancer Biology, College of Medicine and Life Sciences, University of Toledo, 3000 Arlington Ave. MS-1010, Toledo, OH 43614, USA. Electronic address:

Na/K-ATPase (the sodium pump) was discovered in the 1950s as the plasma membrane enzyme that carries out the coupled active transports of Na and K across the membranes of nearly all eukaryotic cells. It was not until the 1990s when it was shown that besides pumping ions, Na/K-ATPase is also capable of stimulus-induced interactions with neighboring proteins that lead to activations of signal transduction pathways causing cell growth. This article is an attempt to review the progress of the research on these signaling functions of sodium pump during the past 2-3 decades.

View Article and Find Full Text PDF

The sodium pump (Na/K-ATPase) is a plasma membrane enzyme that transports Na and K against their physiological gradients in most eukaryotic cells. Besides pumping ions, the enzyme may also interact with neighboring proteins to activate cell signaling pathways that regulate cell growth. Digitalis drugs, useful for the treatment of heart failure and atrial arrhythmias, inhibit the pumping function of Na/K-ATPase and stimulate its signaling function.

View Article and Find Full Text PDF

Non-β-Blocking Carvedilol Analog, VK-II-86, Prevents Ouabain-Induced Cardiotoxicity.

Circ J

December 2018

Centro de Investigaciones Cardiovasculares, CONICET La Plata, Facultad de Ciencias Médicas, Universidad Nacional de La Plata.

Background: It has been shown that carvedilol and its non β-blocking analog, VK-II-86, inhibit spontaneous Ca release from the sarcoplasmic reticulum (SR). The aim of this study is to determine whether carvedilol and VK-II-86 suppress ouabain-induced arrhythmogenic Ca waves and apoptosis in cardiac myocytes.

Methods and results: Rat cardiac myocytes were exposed to toxic doses of ouabain (50 µmol/L).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!